Taxotere News and Research

RSS
Taxotere is a drug used together with other drugs to treat certain types of breast cancer, stomach cancer, prostate cancer, and certain types of head and neck cancer. It is also being studied in the treatment of other types of cancer. Taxotere is a type of mitotic inhibitor. Also called docetaxel.
Cell Genesys reports data from clinical trials of GVAX immunotherapy for prostate cancer

Cell Genesys reports data from clinical trials of GVAX immunotherapy for prostate cancer

New chemical agent, MCP110, provides synergistic effect to standard drugs

New chemical agent, MCP110, provides synergistic effect to standard drugs

New understanding of how and why Taxol works in patients with breast cancer

New understanding of how and why Taxol works in patients with breast cancer

Asentar for prostate cancer, a potential blockbuster

Asentar for prostate cancer, a potential blockbuster

New treatment option gives hope to victims of  head and neck cancers

New treatment option gives hope to victims of head and neck cancers

FDA approves Taxotere for head and neck cancers

FDA approves Taxotere for head and neck cancers

Advanced prostate cancer can be treated successfully with intermittent chemotherapy

Advanced prostate cancer can be treated successfully with intermittent chemotherapy

Taxotere combined with standard chemotherapy improves survival in advanced head and neck cancers

Taxotere combined with standard chemotherapy improves survival in advanced head and neck cancers

Prostate cancer research may be faster with prostate-specific antigen endpoints

Prostate cancer research may be faster with prostate-specific antigen endpoints

Substance found in evening primrose oil inhibits breast cancer gene

Substance found in evening primrose oil inhibits breast cancer gene

DN-101 may protect against major side effects of chemotherapy

DN-101 may protect against major side effects of chemotherapy

Government in Ontario will pay for three new cancer drugs

Government in Ontario will pay for three new cancer drugs

Vitamin D, taxotere combination promising for advanced prostate cancer

Vitamin D, taxotere combination promising for advanced prostate cancer

Study shows the longest reported survival rate for patients with locally advanced lung cancer

Study shows the longest reported survival rate for patients with locally advanced lung cancer

Taxotere shows significant survival benefit in the treatment of advanced gastric cancer

Taxotere shows significant survival benefit in the treatment of advanced gastric cancer

Drug trio increases survival rate in head and neck cancers

Drug trio increases survival rate in head and neck cancers

Phenoxodiol increases the effectiveness of Docetaxel by at least 100 times

Phenoxodiol increases the effectiveness of Docetaxel by at least 100 times

European approval for Taxotere (docetaxel) in prostate cancer

European approval for Taxotere (docetaxel) in prostate cancer

Genetic predictions may bring “quantum leap” in breast cancer treatment success

Genetic predictions may bring “quantum leap” in breast cancer treatment success

Breast cancer drug Taxotere extends life of prostate cancer patients

Breast cancer drug Taxotere extends life of prostate cancer patients